---  
layout: startup_page  
title: "Halia Therapeutics"  
id: "haliatx.com"  
permalink: "/haliatherapeuticshaliatx.com01312024/"  
website: "https://www.haliatx.com"  
funding_round: "Series C"  
funding_amount: "$30M"  
investors: "Todd Pedersen"  
about: "Halia Therapeutics is a clinical-stage biopharmaceutical company developing small molecule medications to combat inflammation. Their lead asset, HT-6184, is a first-in-class NLRP3/NEK7 inflammasome inhibitor currently in Phase II clinical trials for various inflammatory diseases. The company also has programs developing LRRK2 inhibitors for neurological diseases."  
markets: "Biopharmaceuticals, Inflammation, Neurology, Biotechnology, Medical, Pharmaceutical"  
hq: "Lehi, Utah, United States"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/halia-therapeutics-inc/"  
twitter: "https://twitter.com/Halia_Tx"  
instagram: ""  
facebook: "https://www.facebook.com/haliatx"  
crunchbase: "https://www.crunchbase.com/organization/halia-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/453337-39"  

date_display: "31-Jan-2024"  
date: "2024-01-31"

# SEO Optimization  
meta_title: "Halia Therapeutics - Series C Funding ($30M)"  
meta_description: "Halia Therapeutics, Halia Therapeutics is a clinical-stage biopharmaceutical company developing small molecule medications to combat inflammation. Their lead asset, HT-61..."  
meta_keywords: "Halia Therapeutics, Biopharmaceuticals, Inflammation, Neurology, Biotechnology, Medical, Pharmaceutical, Series C funding"  
canonical_url: "https://startup.projectstartups.com/haliatherapeuticshaliatx.com01312024/"  
---